{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:00:58Z","timestamp":1789563658194,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The outbreak of Coronavirus disease of 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has posed a serious health threat. The increasing number of COVID-19 cases around the world is overwhelming hospitals and pushing the global death toll to over 746,000, which has pushed the sprint to find new treatment options. In this article, we reviewed the SARS-CoV-2 pathophysiology, transmission, and potential treatment strategies.<\/jats:p>","DOI":"10.1186\/s12967-020-02520-8","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T14:03:53Z","timestamp":1600178633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Pathophysiology and treatment strategies for COVID-19"],"prefix":"10.1186","volume":"18","author":[{"given":"Manoj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4858-7130","authenticated-orcid":false,"given":"Souhaila","family":"Al Khodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"2520_CR1","unstructured":"Organization WH: Rolling updates on coronavirus disease (COVID-19). 2020. https:\/\/wwww.hoint\/emergencies\/diseases\/novel-coronavirus-2019\/events-as-they-happen."},{"issue":"7798","key":"2520_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265\u20139.","journal-title":"Nature"},{"key":"2520_CR3","unstructured":"Organization WH: WHO Timeline\u2014COVID-19. 2020. https:\/\/www.who.int\/news-room\/detail\/27-04-2020-who-timeline\u2014covid-19."},{"key":"2520_CR4","doi-asserted-by":"crossref","unstructured":"Koo JR, Cook AR, Park M, Sun Y, Sun H, Lim JT, Tam C, Dickens BL. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis. 2020.","DOI":"10.1016\/S1473-3099(20)30162-6"},{"issue":"3","key":"2520_CR5","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.","journal-title":"Int J Antimicrob Agents"},{"key":"2520_CR6","first-page":"4","volume":"9","author":"M Park","year":"2020","unstructured":"Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9:4.","journal-title":"J Clin Med"},{"issue":"19","key":"2520_CR7","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814\u201320.","journal-title":"N Engl J Med"},{"issue":"20","key":"2520_CR8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"C Drosten","year":"2003","unstructured":"Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967\u201376.","journal-title":"N Engl J Med"},{"issue":"10223","key":"2520_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"China. Lancet"},{"issue":"9393","key":"2520_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","volume":"362","author":"NS Zhong","year":"2003","unstructured":"Zhong NS, Zheng BJ, Li YM, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet. 2003;362(9393):1353\u20138.","journal-title":"Lancet"},{"issue":"2","key":"2520_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","volume":"14","author":"BL Haagmans","year":"2014","unstructured":"Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, Godeke GJ, Jonges M, Farag E, Diab A, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 2014;14(2):140\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"2520_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199\u2013207.","journal-title":"N Engl J Med"},{"key":"2520_CR13","unstructured":"WHO: Coronavirus disease 2019 (COVID-19) situation report\u201355. In., March 15, 2020 edn. 2020 https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_8."},{"issue":"2","key":"2520_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.24171\/j.phrp.2020.11.2.03","volume":"11","author":"MA Khafaie","year":"2020","unstructured":"Khafaie MA, Rahim F. Cross-country comparison of case fatality rates of COVID-19\/SARS-COV-2. Osong Public Health Res Perspect. 2020;11(2):74\u201380.","journal-title":"Osong Public Health Res Perspect"},{"key":"2520_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1\u201323.","journal-title":"Methods Mol Biol"},{"issue":"10223","key":"2520_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"key":"2520_CR17","doi-asserted-by":"crossref","unstructured":"Licastro D, Rajasekharan S, Dal Monego S, Segat L, D\u2019Agaro P, Marcello A, Regione FVGLGoC. Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy. J Virol. 2020.","DOI":"10.1128\/JVI.00543-20"},{"issue":"3","key":"2520_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","volume":"27","author":"A Wu","year":"2020","unstructured":"Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325\u20138.","journal-title":"Cell Host Microbe"},{"key":"2520_CR19","doi-asserted-by":"crossref","unstructured":"Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020.","DOI":"10.1016\/j.apsb.2020.02.008"},{"issue":"2","key":"2520_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u201380.","journal-title":"Cell"},{"issue":"6","key":"2520_CR21","doi-asserted-by":"publisher","first-page":"101212","DOI":"10.1016\/j.isci.2020.101212","volume":"23","author":"JA Jaimes","year":"2020","unstructured":"Jaimes JA, Millet JK, Whittaker GR. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1\/S2 site. IScience. 2020;23(6):101212.","journal-title":"IScience"},{"issue":"1","key":"2520_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","volume":"16","author":"D Schoeman","year":"2019","unstructured":"Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019;16(1):69.","journal-title":"Virol J"},{"key":"2520_CR23","unstructured":"CDC: Coronavirus Disease 2019 (COVID-19). In. Edited by Prevention CfDCa. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"2520_CR24","doi-asserted-by":"crossref","unstructured":"Vincent JL, Taccone FS. Understanding pathways to death in patients with COVID-19. Lancet Respir Med. 2020.","DOI":"10.1016\/S2213-2600(20)30165-X"},{"key":"2520_CR25","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020.","DOI":"10.1001\/jama.2020.1585"},{"key":"2520_CR26","unstructured":"AA: Chronic illness raises risk from COVID-19: Expert. https:\/\/www.aacomtr\/en\/health\/chronic-illness-raises-risk-from-covid-19-expert\/1791249. vol. 03.04.2020. Yesim Sert Karaaslan; 2020."},{"issue":"4","key":"2520_CR27","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.","journal-title":"Lancet Respir Med"},{"key":"2520_CR28","unstructured":"Guan WJ, Zhong NS. Clinical Characteristics of Covid-19 in China. Reply. N Engl J Med. 2020."},{"key":"2520_CR29","first-page":"7","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:7.","journal-title":"J Virol"},{"key":"2520_CR30","unstructured":"Organization. WH: \u2018Solidarity\u2019 clinical trial for COVID-19 treatment. In., March 20, 2020 edn. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments. WHO; 2020."},{"issue":"7594","key":"2520_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531(7594):381\u20135.","journal-title":"Nature"},{"key":"2520_CR32","doi-asserted-by":"publisher","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","volume":"248","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020;248:117477.","journal-title":"Life Sci"},{"key":"2520_CR33","unstructured":"SILVERMAN E: New data on Gilead\u2019s remdesivir, released by accident, show no benefit for coronavirus patients. Company still sees reason for hope. Stat News. 2020."},{"key":"2520_CR34","unstructured":"Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment."},{"issue":"2","key":"2520_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","volume":"6","author":"A Savarino","year":"2006","unstructured":"Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006;6(2):67\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"6485","key":"2520_CR36","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.367.6485.1412","volume":"367","author":"K Kupferschmidt","year":"2020","unstructured":"Kupferschmidt K, Cohen J. Race to find COVID-19 treatments accelerates. Science. 2020;367(6485):1412\u20133.","journal-title":"Science"},{"key":"2520_CR37","doi-asserted-by":"crossref","unstructured":"Christian Funck-Brentano J-ES. Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? Lancet 2020.","DOI":"10.1016\/S0140-6736(20)31174-0"},{"key":"2520_CR38","unstructured":"Organization WH: WHO suspends hydroxychloroquine trials for COVID-19. 2020. https:\/\/www.aa.com.tr\/en\/latest-on-coronavirus-outbreak\/who-suspends-hydroxychloroquine-trials-for-covid-19\/1853478."},{"issue":"5","key":"2520_CR39","first-page":"1023","volume":"4","author":"A Chandwani","year":"2008","unstructured":"Chandwani A, Shuter J. Lopinavir\/ritonavir in the treatment of HIV-1 infection: a review. Ther Clin Risk Manag. 2008;4(5):1023\u201333.","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"2520_CR40","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","volume":"63","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, et al. alpha-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment. J Med Chem. 2020;63(9):4562\u201378.","journal-title":"J Med Chem"},{"issue":"19","key":"2520_CR41","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787\u201399.","journal-title":"N Engl J Med"},{"key":"2520_CR42","unstructured":"Trials C: COVID-19. 2020. https:\/\/clinicaltrialsgov\/ct2\/results?cond=COVID-19&term=drugs&cntry=&state=&city=&dist=&Search=Search."},{"issue":"3","key":"2520_CR43","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1142\/S0192415X20500378","volume":"48","author":"KW Chan","year":"2020","unstructured":"Chan KW, Wong VT, Tang SCW. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med. 2020;48(3):737\u201362.","journal-title":"Am J Chin Med"},{"key":"2520_CR44","doi-asserted-by":"crossref","unstructured":"Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L et al: Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020.","DOI":"10.1001\/jama.2020.4783"},{"issue":"7799","key":"2520_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/d41586-020-00751-9","volume":"579","author":"S Jiang","year":"2020","unstructured":"Jiang S. Don\u2019t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature. 2020;579(7799):321.","journal-title":"Nature"},{"key":"2520_CR46","unstructured":"Busniness S: LIVE BLOG: R&D response to COVID-19 pandemic. https:\/\/sciencebusiness.net\/covid-19\/news\/live-blog-rd-response-covid-19-pandemic. Accessed 13 May 2020."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02520-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T23:43:56Z","timestamp":1631663036000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02520-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2520"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02520-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final version of the manuscript and approved it for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}